CNS & Neurological Disorders - Drug Targets
Title:Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle
Volume: 15 Issue: 7
Author(s): Julie Deguil, Alexandra Auffret, Esther Schenker, Fabienne Aujard, Yves Lamberty, David Bartrès-Faz, Olivier Blin, Joëlle Micallef, Jill C. Richardson and Régis Bordet
Affiliation:
Export Options
About this article
Cite this article as:
Deguil Julie, Auffret Alexandra, Schenker Esther, Aujard Fabienne, Lamberty Yves, Bartrès-Faz David, Blin Olivier, Micallef Joëlle, Richardson C. Jill and Bordet Régis, Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle, CNS & Neurological Disorders - Drug Targets 2016; 15 (7) . https://dx.doi.org/10.2174/187152731507160808200737
DOI https://dx.doi.org/10.2174/187152731507160808200737 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Extracellular Matrix Remodeling in Hypertension
Current Hypertension Reviews Computational Advances in Chronic Diseases Diagnostics and Therapy - II
Current Drug Targets Current Status and Future Prospective of Immunointervention in Multiple Sclerosis
Current Medicinal Chemistry MR Spectroscopy Findings of the Basal Ganglia in Bipolar Disorders: a Systematic Review
Current Psychiatry Reviews Matrix Factorization-based Improved Classification of Gene Expression Data
Recent Advances in Computer Science and Communications Molecular Basis of Familial and Sporadic Alzheimer's Disease
Current Alzheimer Research Transferrin and the Transferrin Receptor: Of Magic Bullets and Other Concerns
Inflammation & Allergy - Drug Targets (Discontinued) Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives
Current Cancer Drug Targets Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Mini-Reviews in Medicinal Chemistry Physical Activity, Insulin Action, and Diabetes Prevention and Control
Current Diabetes Reviews Astrocytes Exert and Control Immune Responses in the Brain
Current Immunology Reviews (Discontinued) Apathy: A Conceptual Review
Current Psychiatry Research and Reviews Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles
Current Alzheimer Research Beam Commissioning Data Acquisition for the Iris Variable Aperture Collimator of CyberKnife VSI
Neuroscience and Biomedical Engineering (Discontinued) Mechanisms of Action of Antiepileptic Drugs
Current Topics in Medicinal Chemistry Acknowledgements to Reviewers
Recent Patents on CNS Drug Discovery (Discontinued) Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain
Medicinal Chemistry Recent Progress in the Pharmacology of Imidazo[1,2-a]pyridines
Mini-Reviews in Medicinal Chemistry Current and Future Therapeutic Strategies for Parkinsons Disease
Current Pharmaceutical Design